Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Real-time, multi-omics intelligence for diagnosis, treatment selection,
& monitoring-engineered for the way modern cancer evolves.
We enable earlier detection, precise treatment selection, and continuous monitoring.
We help identify the right patients, track response, and validate targets.
We provide deep, single-cell multi-omics insights across disease progression.
Four integrated capabilities, working as one continuous
intelligence layer between biology and clinical action.
Powered by platforms like OncoIndx and comprehensive multi-omics profiling.
Enabling proactive, not reactive, care.
Powered by platforms like OncoIndx and comprehensive multi-omics profiling.
From discovery through companion diagnostic.
A continuous workflow connecting wet-lab biology to AI-driven clinical reasoning, delivered as a single intelligible report.
Blood or tissue samples
ctDNA, CTCs, RNA, and protein profiling
Integration of complex biological data and analysis
Clear insights for treatment and monitoring decisions
Transforming how cancer is managed — one step at a time.
molecular-level signal vs. imaging
precision-matched regimens
lower toxicity, fewer side effects
A unified, AI-driven, single-cell multi-omics platform — replacing
fragmented tools with one continuous intelligence.
| Dimension | – Traditional Approaches | + iCell.ai Platform |
|---|---|---|
| Data type | Single modality (genomics or liquid biopsy) | Unified multi-omics: DNA · RNA · protein · CTCs · ctDNA |
| Resolution | Bulk tissue averages | Single-cell, longitudinal |
| Timing | Static snapshots, months apart | Real-time monitoring of evolving disease |
| Intelligence | Manual interpretation, fragmented reports | AI-driven, integrated clinical reasoning |
| Workflow | Isolated tools, disconnected hand-offs | Sample → decision in one continuous platform |